Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections

Vancomycin remains the mainstay treatment for methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections (BSIs) despite increased treatment failures. Daptomycin has been shown to improve clinical outcomes in patients with BSIs caused by MRSA isolates with vancomycin MICs of >1 mg/l...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Agents Chemother
Main Authors: Claeys, Kimberly C., Zasowski, Evan J., Casapao, Anthony M., Lagnf, Abdalhamid M., Nagel, Jerod L., Nguyen, Cynthia T., Hallesy, Jessica A., Compton, Mathew T., Kaye, Keith S., Levine, Donald P., Davis, Susan L., Rybak, Michael J.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2016
Assuntos:
Clinical Therapeutics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5038271/
https://ncbi.nlm.nih.gov/pubmed/27431221
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00227-16
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados